Tina D Cunningham Selected Research

Tina D Cunningham Research Topics

3	Inflammation (Inflammations) 01/2016 - 11/2015
2	Sleep Apnea Syndromes (Sleep Apnea) 10/2019 - 01/2018
2	Apnea 10/2019 - 01/2018
2	Lower Urinary Tract Symptoms 03/2017 - 02/2017
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 03/2017 - 02/2017
2	Hepatitis C 01/2016 - 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 08/2022
1	Disease Progression 08/2022
1	Cleft Palate (Palate, Cleft) 03/2021
1	Atrophy 01/2020
1	Obstructive Sleep Apnea 10/2019
1	Tobacco Use Disorder (Nicotine Dependence) 01/2017
1	Substance-Related Disorders (Drug Abuse) 01/2017
1	Cerebral Palsy (Spastic Diplegia) 04/2016
1	Coinfection 01/2016
1	Rhinosinusitis 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Hypersensitivity (Allergy) 01/2016
1	Infections 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Metaplasia 01/2016
1	Nasal Polyps (Nasal Polyp) 01/2016
1	HIV Infections (HIV Infection) 01/2016
1	Lichen Planus (Lichen Ruber Planus) 02/2013

2	Biomarkers (Surrogate Marker)IBA 01/2016 - 11/2015
1	AntigensIBA 08/2022
1	Polysaccharides (Glycans)IBA 08/2022
1	GlycopeptidesIBA 08/2022
1	ZincIBA 01/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2019
1	montelukast (Singulair)FDA Link 10/2019
1	Leukotriene E4IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2016
1	CreatinineIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	InterleukinsIBA 01/2016
1	NucleosidesIBA 01/2016
1	Interleukin-9 (Interleukin 9)IBA 01/2016
1	Reverse Transcriptase InhibitorsIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Metronidazole (Metric)FDA LinkGeneric 11/2015
1	apremilastIBA 02/2013

2	Suburethral Slings (Tension-Free Vaginal Tape) 03/2017 - 02/2017
2	Therapeutics 01/2016 - 11/2015
1	Length of Stay 03/2021
1	Patient Readmission 01/2017
1	Mechanical Ventilators (Ventilator) 04/2016